METASTATIC MALIGNANT NEOPLASM IN THE LYMPH NODES
Clinical trials for METASTATIC MALIGNANT NEOPLASM IN THE LYMPH NODES explained in plain language.
Never miss a new study
Get alerted when new METASTATIC MALIGNANT NEOPLASM IN THE LYMPH NODES trials appear
Sign up with your email to follow new studies for METASTATIC MALIGNANT NEOPLASM IN THE LYMPH NODES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for tough kidney cancer
Disease control OngoingThis study tests whether adding the targeted therapy cabozantinib to standard immunotherapy (nivolumab and ipilimumab) helps people with advanced kidney cancer live longer. About 1,175 adults with kidney cancer that has spread will receive either the usual treatment or the usual …
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE LYMPH NODES
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 02, 2026 04:00 UTC
-
New cocktail of drugs aimed at halting bone metastases in prostate cancer
Disease control TerminatedThis study tests a combination of three drugs—radium-223, M3814, and avelumab—in men with advanced prostate cancer that no longer responds to hormone therapy and has spread to the bone. The goal is to see if the combination can slow cancer growth better than radium-223 alone. The…
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE LYMPH NODES
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New proton beam therapy aims to zap head and neck cancer with fewer side effects
Disease control OngoingThis study is testing whether a precise form of radiation called proton therapy can control head and neck cancer after surgery as well as standard X-ray radiation, but with fewer side effects. About 174 adults with newly diagnosed head and neck cancer will receive either proton t…
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE LYMPH NODES
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New combo attack on returning prostate cancer shows promise
Disease control OngoingThis phase 2 trial is testing whether surgery and radiation can help men whose prostate cancer has come back and spread to a few spots in the body. About 20 participants will receive either surgery to remove the spread tumors or targeted radiation, or both. The main goal is to se…
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE LYMPH NODES
Phase: PHASE2 • Sponsor: University of Utah • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC